MetaCap

Quest Diagnostics Statistics

NYSE: DGXHealth CareMedical SpecialitiesUSD

227.06-1.33 (-0.58%)

At close: Oct 7, 4:04 PM ET · Delayed 15 min

Pre-market: 226.45 -0.27%

Quest Diagnostics by the numbers

Quest Diagnostics has a market capitalization of $25.06 billion based on 110.37M shares outstanding. Its trailing P/E ratio is 24.1, below the 5-company peer median of 25.5, and its forward P/E is 18.8. The stock trades 4.4% below its 50-day average and 9.8% above its 200-day average.

Average daily trading volume is 1.04M shares, or about $235.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DGX valuation vs. peer median

DGX compared with the median of 8 peer companies
MetricDGXPeer medianDifference
Market cap$25.06B$16.38B+53%
P/E (TTM)24.125.5-6%
Forward P/E18.815.7+20%
Avg. volume1.04M2.34M-56%

Peer median across 8 companies: LH, GH, CNC, MOH, OSCR, ILMN, HSIC, CAI.

Valuation

Market cap
$25.06B
Price / sales (latest FY)
2.27

Price and trading

Previous close
228.39
Open
228.51
Day range
226.81 – 229.80
52-week range
171.18 – 248.84
52-week change
+24.83%
Beta
—
Volume
927.41K

Dividends and events

Annual dividend
$3.32
Next earnings date
Oct 22, 2026

Additional statistics

Market Cap
25.06B
Pe
24.10
Forward Pe
18.84
Eps
9.42
Dividend Yield
1.52%
Dividend Rate
3.32
Week52 High
248.84
Week52 Low
171.18
Avg Volume
1.04M
Shares Outstanding
110.37M
Ma50
237.63
Ma200
206.85
Earnings Date
Oct 22, 2026
Pct From52w High
-8.75%
Pct From52w Low
32.64%

Related